Dutch metabolic disease specialist NorthSea Therapeutics NV has baged US$80m in a Series C fundraising co-led...
Up To Date
Latest News
French-British magnetic trap specialist Depixus has raised €30,6m to develop a commercial instrument based on...
Ichnos Sciences Inc. has licenced the gobal rights on its IL-1RAP antagonistic antibody ISB 880 to Almirall SA...
Biologicals and vaccine specialist CSL Ltd is set to acquire Swiss Vifor Pharma Ltd for CHF10.9bn.
German Apogenix AG has received a €26m in funding for a pivotal Phase III study of its CD95 ligand blocker...
The 2021 spin out of London-based Francis Crick Institute is the very first UK company formation deal of life...